TSS
HUMA icon

Two Sigma Securities’s Humacyte HUMA Stock Holding History

Two Sigma Securities’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,759
Closed -$7.74K – 2016
2026
Q1 		$7.74K Buy
+12,759
New +$13.3K ﹤0.01% 1490
2025
Q4 		– Sell
-14,891
Closed -$25.9K – 1712
2025
Q3 		$25.9K Buy
+14,891
New +$29.2K ﹤0.01% 1088

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Securities's HUMA Position: Q2 2026 in Review

Two Sigma Securities sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 12,759 shares — an estimated $7.74K sold.

Two Sigma Securities first reported a position in HUMA in Q3 2025 and held it in 2 quarters. The position peaked at $25.9K in Q3 2025. 164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Two Sigma Securities reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 12,759 Humacyte shares in Q2 2026, an estimated $7.74K.
  • Two Sigma Securities first reported a position in Humacyte in Q3 2025 and held it in 2 quarters.
  • Two Sigma Securities's Humacyte position peaked at $25.9K in Q3 2025.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.